 Goldman Sachs Group Inc. cut its stake in Odonate Therapeutics Inc NASDAQ:ODT by 52.6 in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission SEC. The institutional investor owned 22,880 shares of the companys stock after selling 25,392 shares during the period. Goldman Sachs Group Inc. owned approximately 0.07 ... 